During the past decade, Hôpital Maison Blanche; Service de Neurologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Maison Blanche; Service de Neurologie" are "Multiple Sclerosis, Primary Progressive" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hôpital Maison Blanche; Service de Neurologie" in a lesser frequency.

Most popular intervention types in "Hôpital Maison Blanche; Service de Neurologie" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Interferon beta-1a" (1 trials), "Interferon beta-1a-matching placebo" (1 trials), "Ocrelizumab-matching placebo" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Maison Blanche; Service de Neurologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Maison Blanche; Service de Neurologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital Maison Blanche; Service de Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Maison Blanche; Service de Neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".